The long Memorial Day weekend didn't slow down the US Food and Drug Administration and industry, which produced a burst of drug development news in the closing days of May. Here's your news in brief:
Regenerative medicine sponsors stole a chunk of the spotlight. Fibrocell Science Inc. reeled in a regenerative medicine advanced therapy...